Strategic Asset Management, LLC Diffusion Pharmaceuticals Inc. Transaction History

Strategic Asset Management, LLC

  • $57.7 Million
  • Q3 2022

A detailed history of Strategic Asset Management, LLC transactions in Diffusion Pharmaceuticals Inc. stock. As of the latest transaction made, Strategic Asset Management, LLC holds 40 shares of DFFN stock, worth $370. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Previous 40 -0.0%
Holding current value
$370
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 14, 2022
BUY
$5.66 - $14.0 $226 - $560
40 New
40 $0

Others Institutions Holding DFFN

# of Institutions
2
Shares Held
49
Call Options Held
0
Put Options Held
0
View Full List

About Diffusion Pharmaceuticals Inc.

DFFN Quotes by TradingView
  • Ticker DFFN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,039,120
  • Market Cap $18.9M
  • Description
  • Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 a...
More about DFFN
Track This Portfolio

Track Strategic Asset Management, LLC Portfolio

Follow Strategic Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email